"Chippewa Falls Center serves the city of Chippewa falls and surrounding Chippewa County. The center offers care in audiology; dermatology; family practice; internal medicine; neurology; nutrition services; obstetrics and gynecology; oncology/hematology; otolaryngology (ENT); pediatrics; general surgery and anesthesiology; physical therapy; physical medicine and rehabilitation; and orthopedics. Clinic Pharmacy services are available on-site."

During the past decade, Marshfield Clinic-Chippewa Center conducted 94 clinical trials. In the 10-year time frame, 94 clinical trials started and 97 clinical trials were completed, i.e. on average, 103.2% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 51 clinical trials were completed. i.e. 231.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marshfield Clinic-Chippewa Center" #1 sponsor was "National Cancer Institute (NCI)" with 74 trials, followed by "SWOG Cancer Research Network" with 37 trials sponsored, "Alliance for Clinical Trials in Oncology" with 33 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "Eastern Cooperative Oncology Group" with 16 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marshfield Clinic-Chippewa Center" #1 collaborator was "National Cancer Institute (NCI)" with 105 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 31 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Marshfield Clinic-Chippewa Center" are "Breast Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Fallopian Tube Transitional Cell Carcinoma" (7 trials) and "Leukemia" (7 trials). Many other conditions were trialed in "Marshfield Clinic-Chippewa Center" in a lesser frequency.

Most popular intervention types in "Marshfield Clinic-Chippewa Center" are "Drug" (142 trials), "Other" (118 trials), "Biological" (69 trials), "Procedure" (36 trials) and "Radiation" (8 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (63 trials), "Quality-of-Life Assessment" (42 trials), "Questionnaire Administration" (21 trials), "Paclitaxel" (19 trials) and "Bevacizumab" (17 trials). Other intervention names were less common.

The vast majority of trials in "Marshfield Clinic-Chippewa Center" are 145 trials for "All" genders, 32 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Marshfield Clinic-Chippewa Center". undefined are not yet recruiting, 28 are recruiting, 76 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 62 completed trials in Marshfield Clinic-Chippewa Center, 1 suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Marshfield Clinic-Chippewa Center, 4 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 100 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".